22.02.2013 Views

Download - Berlin School of Mind and Brain

Download - Berlin School of Mind and Brain

Download - Berlin School of Mind and Brain

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Barbara Trattner<br />

Optogenetics<br />

Optogenetics is an elegant emerging method in neuroscience, which exploits optical <strong>and</strong><br />

genetic tools to precisely control neuronal brain circuits in living animals at a high<br />

temporal <strong>and</strong> spatial resolution. Generally neuronal properties are investigated with the<br />

help <strong>of</strong> selective pharmacological agents targeting certain neuronal structures. These<br />

agents are however disadvantageous in that they have a systemic action, are temporally<br />

imprecise <strong>and</strong> may cause unspecific side-effects. In addition to replacing pharmacology,<br />

optogenetic approaches can also substitute electrical stimulation <strong>of</strong> a neuronal population<br />

for defined light-gated activation. Photosensitive proteins can be artificially expressed in<br />

neurones to alter their firing properties <strong>and</strong> thereby information processing. By exposing<br />

only a certain brain area to light, only the activity <strong>of</strong> those neurones will be modulated by<br />

the photosensitive proteins. Due to the immense possibilities that optogenetics <strong>of</strong>fer in<br />

elucidating neuronal brain circuits, it was selected the method <strong>of</strong> the year 2010 by the<br />

prestigious scientific journal Nature Methods. The principle <strong>of</strong> using optogenetics was<br />

first found around 2000, when photosensitive proteins were expressed in neurones, which<br />

could thereby be sensitised to light. Further research in the field <strong>of</strong> optogenetics led to the<br />

implementation <strong>of</strong> genetically-encoded bacterial <strong>and</strong> algeal photosensitive ion channels<br />

<strong>and</strong> pumps in neurones. Depending on the properties <strong>of</strong> these ion transporters, they can<br />

either hyperpolarise or depolarise neurones. An advantage <strong>of</strong> using photosensitive ion<br />

transporters to targeting endogenous channels with drugs is the fast time constant: Upon<br />

illumination with the correct wavelength, photosensitive channels open <strong>and</strong> close in the<br />

range <strong>of</strong> milliseconds. A lot <strong>of</strong> research is currently going on to develop new artificial<br />

light-gated ion channels or receptors. With the help <strong>of</strong> tissue-specific promoters, these<br />

proteins can be expressed only in a certain neuronal subgroup or at a confined<br />

developmental stage.<br />

Precisely choosing the brain area, which is exposed to light, allows the further refinement<br />

<strong>of</strong> the subgroup <strong>of</strong> modulated neurones. By expressing photosensitive proteins in a<br />

subclass <strong>of</strong> neurones responsible for a defined behaviour, researchers can nowadays<br />

control behaviour by exciting or inhibiting only those neurones with light. Flies for<br />

instance can learn that a certain odour is aversive when the odour is paired with the lightgated<br />

activation <strong>of</strong> a certain receptor class. Mice can be woken up when a certain neuronal<br />

population <strong>of</strong> the hypothalamus, artificially expressing photosensitive proteins, are<br />

stimulated with light.<br />

The therapeutic aim <strong>of</strong> optogenetics for humans is to restore vision after a degeneration <strong>of</strong><br />

photoreceptor cells in the retina. In mice it was shown that equipping retinal neurones<br />

with photosensitive proteins from microbes using a viral delivery can restore visual<br />

responses. In humans this approach is currently investigated in inherited retinal<br />

dysfunctions: In Leber’s congenital amaurosis patient lack a certain pigment protein <strong>of</strong><br />

the retina. Subretinal administration <strong>of</strong> viral vectors encoding the absent pigment, lead to<br />

a long-lasting improvement in vision perception. However optogenetic treatments are not<br />

yet st<strong>and</strong>ard in the therapy <strong>of</strong> blindness, mainly due to the fact that viral gene transfer<br />

bears many risks.<br />

9

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!